COVID-19 Research at the University of Alberta

As the COVID-19 global pandemic continues to spread, affecting billions of people and every facet of life, the University of Alberta is here to help.

April 02, 2020

Biochemistry professor Joanne Lemieux leads a U of A team that identified promising compounds known as protease inhibitors that interfere with the SARS-CoV-2 virus's ability to replicate — potentially pointing the way to new antiviral treatments that would be more effective with fewer toxic side-effects. (Photo: John Ulan)
Health And Wellness, Research

U of A team uncovers new compounds to slow SARS-CoV-2 replication mechanism

Novel protease inhibitors show promise for developing safer, more effective COVID-19 treatments.

  • October 21, 2021
  • By Gillian Rutherford
Andrew MacIsaac, CEO of Applied Pharmaceutical Innovation, an industry-led non-profit, says a partnership with the University of Alberta will help to fill urgent gaps in Canada’s pharmaceutical supply chain — and get new life-saving treatments to market faster. (Photo: API)
Research, Business, Science and Technology, Health And Wellness

U of A-industry partnership poised to close Canada’s drug supply gaps

The Canadian Critical Drug Initiative aims to transform Alberta into a powerhouse in the development of life-saving therapies.

  • November 02, 2021
  • By Niall McKenna
Research, Health And Wellness

Long COVID: ‘Is this going to be my new normal?’

U of A researchers are partnering to help improve life for Canadians dealing with lingering symptoms of COVID-19.

  • October 29, 2021
  • By Michael Brown

More COVID-19 stories from the University of Alberta

Loading...